Viridian reports positive news from ongoing trial for patients with Thyroid Eye Disease
Patients with active thyroid eye disease (TED) could benefit from rapid and significant improvements after…
Within San Diego lies one of the biggest biotech hubs in the U.S. We’ve listed…
Merck, also known as MSD outside the U.S. and Canada, and Orna Therapeutics, a biotech…
Remedium Bio, Inc., a biotech company developing novel gene therapies, has closed more than $2.3…
Patients with active thyroid eye disease (TED) could benefit from rapid and significant improvements after…
U.S.-headquartered Senda Biosciences, Inc. has completed $123 million in series C financing, bringing its total…
The first patient has been dosed in a phase 1 trial evaluating a monotherapy treatment…
ADC Therapeutics has announced a series of major strategic transactions involving hundreds of millions of…
A study looking at a treatment for primary biliary cholangitis (PBC) has this month (August)…
Biotech company Pneumagen says the first person has been dosed in its phase 2 controlled…
Following a positive opinion from the European Medicines Agency (EMA), the European Commission (EC) has…
Genentech, a part of the Roche Group, says the U.S. Food and Drug Administration (FDA)…
During drug development, biologics often fail to transition from the preclinical to the clinical stage,…